Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Singapore Catalist Market  >  TalkMed Group Limited    5G3   SG2G61000003

TALKMED GROUP LIMITED

(5G3)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • Historically, the company has been releasing figures that are above expectations.
Weaknesses
  • The stock is close to a major daily resistance at SGD 0.46, which should be gotten rid of so as to gain new appreciation potential.
  • The underlying tendency is negative on the weekly chart below the resistance at 0.45 SGD
Ratings chart
Sector Healthcare Facilities & Services - Other
1st jan.Capitalisation (M$)Investor Rating
TALKMED GROUP LIMITED0.00%446
-
CVS HEALTH CORPORATION6.03%94 792
HCA HEALTHCARE, INC.-4.52%53 132
FRESENIUS MEDICAL CARE AG &..1.50%24 522
LABORATORY CORPORATION OF A..5.53%20 922
QUEST DIAGNOSTICS5.72%16 862
PING AN HEALTHCARE AND TECH..-1.70%13 986
DAVITA INC.0.38%13 199
UNIVERSAL HEALTH SERVICES-8.59%10 681
MEINIAN ONEHEALTH HEALTHCAR..34.42%8 822
CHEMED CORPORATION-2.56%8 279
ENCOMPASS HEALTH CORPORATIO..-0.37%8 191
R1 RCM INC.0.42%6 174
RYMAN HEALTHCARE LIMITED4.61%5 671
JINXIN FERTILITY GROUP LIMI..9.37%5 173
TENET HEALTHCARE CORPORATIO..20.84%5 091
More Results
Financials
Sales 2020 57,1 M 42,9 M 42,9 M
Net income 2020 21,6 M 16,2 M 16,2 M
Net Debt 2020 - - -
P/E ratio 2020 22,5x
Yield 2020 2,22%
Capitalization 593 M 446 M 445 M
Capi. / Sales 2020 10,4x
Capi. / Sales 2021 9,90x
Nbr of Employees -
Free-Float 16,7%
Upcoming event on TALKMED GROUP LIMITED
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality
Business Predictability -
P/E ratio -
Potential
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes